Flynn Patrick John's Form 4 filing
NRX Pharmaceuticals, Inc. (NRXP) · filed Nov 29, 2022
- Accession no.
- 0001415889-22-011810
- Filed
- Nov 29, 2022
- Trade date
- Nov 28, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $14.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flynn Patrick JohnCIK 0001864871 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,500 | $1.25 | +$3,125 | 37,709 | Indirect | |
| Nov 28, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,500 | $1.25 | +$3,125 | 40,209 | Indirect | |
| Nov 28, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,500 | $1.25 | +$3,125 | 37,709 | Indirect | |
| Nov 28, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,500 | $1.24 | +$3,100 | 40,209 | Indirect | |
| Nov 28, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,750 | $1.25 | +$2,187.5 | 1,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.